Articles Mentioning Biotechnology Stocks

Results 1 - 10 of 338 : 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Biotechnology

Investing | October 08, 2015

3 Pharma Stocks With Big Margins of Safety

Looking to add a few stocks to your portfolio that offer a healthy margin of safety? Here are a few names to consider.

Investing | September 29, 2015

Is Gilead Sciences' Dominance in Hepatitis C Unstoppable?

Four new late-stage studies from Gilead Sciences demonstrate that it's once again raised the bar in treating hepatitis C. Can anything stop Gilead?

Investing | September 20, 2015

3 Stocks Battling Heart Disease: 2 to Buy, 1 to Sell

Companies are rolling out cardiovascular drugs in a bid to tap into a massive and growing market, but not every one of these companies belongs in investor portfolios.

Investing | September 04, 2015

PCSK9 Drugs Are Here (and Way Over There)

As the first generation of the cholesterol-lowering drugs hits the market, investors should already be looking at the next-generation products.

Investing | August 21, 2015

3 Low-Price Biotech Stocks That Could Pop or Drop in 2016

Agenus Inc., Array BioPharma, and Idera Pharmaceuticals are expecting to release data from cancer drug trials in the coming year.

Investing | July 18, 2015

These 2 Stocks Doubled in 2015 -- Is 1 Still a Buy?

Advaxis and Agenus have been two of the best performing stocks of 2015. Can they continue to crush the broader markets or is it time to take profits?

Investing | July 14, 2015

Midyear Report Card: Grading My Biotech Predictions for 2015

One Foolish investor shines a bright light on his biotech stocks predictions for this year.

Investing | June 27, 2015

Is it Time for this Biotech to Change Management?

With Aegerion Pharmaceuticals down 500% from its all-time high, the current CEO's tenure is trying investors' patience.

Investing | June 11, 2015

3 Things AbbVie Inc.'s Management Wants You to Know

AbbVie's management team had a lot to talk about on their last investor conference call. Here are my three takeaways you need to know when considering the stock for investment.

Investing | June 10, 2015

Cancer Stocks: 2 to Sell, 1 to Buy

Advaxis, Ariad Pharmaceuticals, and Exelixis Inc. are three cancer fight companies that could generate out-sized gains for investors. A deeper look, however, suggests that only one company is a compelling buy right now.

Results 1 - 10 of 338 : 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Biotechnology